Breslow density ability to predict melanoma survival: should it be used in clinical practice?
Pedro Gil-PallaresOlalla Figueroa-SilvaLaura Taboada-PazMaría Eugenia Gil-PallaresMaría Dolores Sánchez-Aguilar RojasVanesa Balboa-BarreiroAlba Navarro-BielsaJosé Manuel Suárez-PeñarandaPublished in: Clinical and experimental dermatology (2024)
BD is proposed as a simple, valuable and inexpensive histopathological feature that could provide with valuable information to current melanoma staging, since it has proved a statistically significant prognostic value in relation to survival in melanoma patients, and comparable 10-year survival prediction ability to BT.